The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration
Open accessPublished version of a preprint
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Complement overactivation mediates microglial synapse elimination in neurological diseases such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD), but how complement activity is regulated in the brain remains largely unknown. We identified that the secreted neuronal pentraxin Nptx2 binds complement C1q and thereby regulates its activity in the brain. Nptx2-deficient mice show increased complement activity, C1q-dependent microglial synapse engulfment, and loss of excitatory synapses. In a neuroinflammation culture model and in aged TauP301S mice, adeno-associated virus (AAV)–mediated neuronal overexpression of Nptx2 was sufficient to restrain complement activity and ameliorate microglia-mediated synapse loss. Analysis of human cerebrospinal fluid (CSF) samples from a genetic FTD cohort revealed reduced concentrations of Nptx2 and Nptx2-C1q protein complexes in symptomatic patients, which correlated with elevated C1q and activated C3. Together, these results show that Nptx2 regulates complement activity and microglial synapse elimination in the brain and that diminished Nptx2 concentrations might exacerbate complement-mediated neurodegeneration in patients with FTD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Experimental evidence further suggests that downregulation of NPTX2 may lead to increased complement-mediated microglial activation, thereby causing abnormal elimination of synapses [43].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 1×
“Blocking C1q binding to neurons is sufficient to attenuate synapse loss in mouse models of AD, FTD, and Huntington’s disease (7, 11, 13).”
BackgroundThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729 · cited 3×
“…to modestly raised CCP activity and moderate loss of excitatory synapses in Nptx2 KO or C4-overexpressing mice, C1q and downstream complement components are highly up-regulated in many chronic neurodegenerative diseases, including AD, FTD, and Huntington ’ s disease ( 7 – 9 , 11 , 13 , 36 , 47 ).”
BackgroundA complement–microglial axis drives synapse loss during virus-induced memory impairment
Vasek, M. J., Garber, C., Dorsey, D., Durrant, D. M., Bollman, B., Soung, A., Yu, J., Perez-Torres, C., Frouin, A., Wilton, D. K., et al. (2016) · Nature · doi:10.1038/nature18283 · Cited by 671 · cited 1×
“This process is overactivated in several central nervous system (CNS) diseases, including AD, virus-induced synapse loss, fronto-temporal dementia (FTD), Huntington ’ s disease, and perhaps schizophrenia, leading to synapse loss and subsequent cognitive decline ( 6 – 12 ).”
BackgroundComplement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593 · cited 2×
“…to modestly raised CCP activity and moderate loss of excitatory synapses in Nptx2 KO or C4-overexpressing mice, C1q and downstream complement components are highly up-regulated in many chronic neurodegenerative diseases, including AD, FTD, and Huntington ’ s disease ( 7 – 9 , 11 , 13 , 36 , 47 ).”
BackgroundDejanovic, B., Huntley, M. A., De Mazière, A., Meilandt, W. J., Wu, T., Srinivasan, K., Jiang, Z., Gandham, V., Friedman, B. A., Ngu, H., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.014 · Cited by 517 · cited 8×
“…has been described for a therapeutical C1q-neutralizing antibody that binds to the head domain of C1q and prevents the interaction of C1q with diverse ligands ( 41 , 42 ), including synapses ( 7 ), and is currently in clinical trials for Hun-tington ’ s disease and amyotrophic lateral sclerosis.”
BackgroundInfluentialSelf-citationSynaptic clustering of AMPA receptors by the extracellular immediate-early gene product narp.
O’Brien, R. J., Xu, D., Petralia, R. S., Steward, O., Huganir, R. L., & Worley, P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80782-5 · Cited by 471
Self-citationWu, T., Dejanovic, B., Gandham, V. D., Gogineni, A., Edmonds, R., Schauer, S., Srinivasan, K., Huntley, M. A., Wang, Y., Wang, T.-M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.060 · Cited by 466
Self-citation
Cited by
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
Targeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 194
Self-citationImam, F. B., Saloner, R., Vogel, J. W., Krish, V. S., Abdel-Azim, G., Ali, M., An, L., Anastasi, F., Bennett, D. A. A., Binette, A. P., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03834-0 · Cited by 187
Oh, H. S.-H., Urey, D. Y., Karlsson, L., Zhu, Z., Shen, Y., Farinas, A., Timsina, J., Duggan, M. R., Chen, J., Guldner, I. H., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03565-2 · Cited by 121
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
“In addition, several proteins that bind to C1q and downstream complement factors protect synapses against excessive elimination in the brain [171, 172].”
BackgroundInflammation in the Peripheral Nervous System after Injury
Gu, D., Xia, Y., Ding, Z., Qian, J., Gu, X., Bai, H., Jiang, M., & Yao, D. (2024) · Biomedicines · doi:10.3390/biomedicines12061256 · Cited by 117
Scott-Hewitt, N., Mahoney, M., Huang, Y., Korte, N., Yvanka de Soysa, T., Wilton, D. K., Knorr, E., Mastro, K., Chang, A., Zhang, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.058 · Cited by 85
Aryal, S., Bonanno, K., Song, B. J., Mani, D. R., Keshishian, H., Carr, S. A., Sheng, M., & Dejanovic, B. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112497 · Cited by 81
Self-citationMolecular mechanisms underlying microglial sensing and phagocytosis in synaptic pruning
Huo, A., Wang, J., Li, Q., Li, M., Qi, Y., Yin, Q., Luo, W., Shi, J., & Cong, Q. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385854 · Cited by 77
CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease
Shen, Y., Timsina, J., Heo, G., Beric, A., Ali, M., Wang, C., Yang, C., Wang, Y., Western, D., Liu, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.049 · Cited by 89
Complement-mediated synapse loss in Alzheimer’s disease: mechanisms and involvement of risk factors
Wen, L., Bi, D., & Shen, Y. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.11.010 · Cited by 71
Tillmon, H., Soteros, B. M., Shen, L., Cong, Q., Wollet, M., General, J., Chin, H., Lee, J. B., Carreno, F. R., Morilak, D. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54007-5 · Cited by 68
Alzheimer’s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response
Wang, Z., Zhang, L., & Qin, C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00857-6 · Cited by 65
CSMD1 regulates brain complement activity and circuit development
Baum, M. L., Wilton, D. K., Fox, R. G., Carey, A. E., Hsu, Y.-H. H., Hu, R., Jäntti, H., Fahey, J. B., Muthukumar, A. K., Salla, N., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.041 · Cited by 52
Molecular mechanisms of schizophrenia: Insights from human genetics
Farsi, Z., & Sheng, M. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102731 · Cited by 64
Self-citationC5aR1 signaling promotes region‐ and age‐dependent synaptic pruning in models of Alzheimer's disease
Gómez-Arboledas, Á., Fonseca, M. I., Kramár, E. A., Chu, S., Schartz, N. D., Selvan, P., Wood, M. A., & Tenner, A. J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13682 · Cited by 54
Microglia phagocytic mechanisms: Development informing disease
Beiter, R. M., Sheehan, P. W., & Schafer, D. P. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102877 · Cited by 44
Knowing the enemy: strategic targeting of complement to treat Alzheimer disease
Tenner, A. J., & Petrisko, T. J. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01073-y · Cited by 55
Yarbro, J. M., Shrestha, H. K., Wang, Z., Zhang, X., Zaman, M., Chu, M., Wang, X., Yu, G., & Peng, J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00874-5 · Cited by 46
Zhang, C., Qi, H., Jia, D., Zhao, J., Xu, C., Liu, J., Cui, Y., Zhang, J., Wang, M., Chen, M., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122457 · Cited by 40
Biomarkers of synaptic degeneration in Alzheimer’s disease
Cheng, Q., Fan, Y., Zhang, P., Liu, H., Han, J., Yu, Q., Wang, X., Wu, S., & Lu, Z. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102642 · Cited by 43
Scott‐Hewitt, N., Huang, Y., & Stevens, B. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15010 · Cited by 24
You, Y., Chen, Z., & Hu, W. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108606 · Cited by 27
Sun, H., Wang, H., Wu, C., Liu, G., He, M., Zhang, H., Hou, F., & Liao, H. (2025) · Stroke · doi:10.1161/strokeaha.124.049265 · Cited by 21
Papanikolaou, A., Graykowski, D. R., Lee, B. I., Yang, M., Ellingford, R. A., Zünkler, J., Bond, S. A., Rowland, J. M., Rajani, R. M., Harris, S., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.010 · Cited by 23
Self-citationLiu, K., Fan, D., Wu, H., Hu, X., He, Q., Wu, X., Shi, C., Yang, J., & Ji, M. (2025) · Aging Cell · doi:10.1111/acel.70167 · Cited by 26
Parvalbumin interneuron cell-to-network plasticity: mechanisms and therapeutic avenues
Hadler, M. D., Alle, H., & Geiger, J. R. P. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.04.003 · Cited by 23
Akinlaja, Y. O., & Nishiyama, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1418100 · Cited by 25
Complement therapeutics in neurodegenerative diseases
Zelek, W. M., & Tenner, A. J. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.153089 · Cited by 21
Plasma proteomic associations with Alzheimer’s disease endophenotypes
Afshar, S., Dammer, E. B., Bian, S., Bennett, D. A., Mohs, R. C., Beauregard, D., Dwyer, J. R., Hales, C. M., Goldstein, F. C., Parker, M. W., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00965-4 · Cited by 30
Li, S., Li, M., Li, G., Li, L., Yang, X., Zuo, Z., Zhang, L., Hu, X., & He, X. (2025) · Aging Cell · doi:10.1111/acel.14496 · Cited by 18
Bai, Q., Shao, E., Ma, D., Jiao, B., Scheetz, S. D., Hartnett, K. A., Ильин, В. Н., Aizenman, E., Kofler, J., & Burton, E. A. (2024) · Nature Communications · doi:10.1038/s41467-024-52173-0 · Cited by 21
Sun, Z., Harshfield, E. L., de Leeuw, F., Burgess, S., Butterworth, A. S., Riksen, N. P., Mallat, Z., & Markus, H. S. (2025) · Stroke · doi:10.1161/strokeaha.124.049079 · Cited by 22
The pentraxin family in autoimmune disease
Li, Y., Zhang, S., Liu, J., Zhang, N., Zhang, N., Cheng, Q., Zhang, H., & Wu, X. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117592 · Cited by 19
Retinal degenerative diseases: Complement system-microglia crosstalk
Gao, J., Wang, W., & Mo, Y. (2025) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2025.08.005 · Cited by 19
Breakthroughs in Alzheimer’s Research: A Path to a More Promising Future?
Fatima, H., Rangwala, H. S., Riaz, F., Rangwala, B. S., & Siddiq, M. A. (2023) · Annals of Neurosciences · doi:10.1177/09727531231187235 · Cited by 14
Yan, T., Wang, R., Yao, J., & Luo, M. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002403 · Cited by 19
Wu, M., Chen, K., Zhao, Y., Jiang, M., Bao, B., Yu, W., Chen, Z., & Yin, X. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14694 · Cited by 15
Loss of function of the zinc finger homeobox 4 gene, ZFHX4, underlies a neurodevelopmental disorder
Baca, M. D. R. P., Palomares‐Bralo, M., Vanhooydonck, M., Hamerlinck, L., D’haene, E., Leimbacher, S., Jacobs, E., Cock, L. D., D’haenens, E., Dheedene, A., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.04.008 · Cited by 22
Massa, F., Martinuzzo, C., José, N. G. D. S., Pelagotti, V., Kreshpa, W., Abu‐Rumeileh, S., Barba, L., Mattioli, P., Orso, B., Brugnolo, A., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12154-7 · Cited by 16
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
Monroe, K. M., Hong, S. Y., Lewcock, J. W., & Yang, A. C. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01370-7 · Cited by 16
Das, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E., & Verberk, I. M. W. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01409-8 · Cited by 12
Selective regulation of corticostriatal synapses by astrocytic phagocytosis
Kim, J. S., Kim, H., Chung, W., & Park, H. (2025) · Nature Communications · doi:10.1038/s41467-025-57577-0 · Cited by 15
Planalp, E. M., Langhough, R. E., Jonaitis, E. M., Hulle, C. A. V., Wilson, R. E., Kollmorgen, G., Quijano‐Rubio, C., Okonkwo, O. C., Bendlin, B. B., Asthana, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-04319-3 · Cited by 14
Emerging perspectives of synaptic biomarkers in ALS and FTD
Krishnamurthy, K., & Pradhan, R. K. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1279999 · Cited by 14
Xing, Y., Shi, H., Gao, X., Zhu, X., Zhang, D., Fang, L., Wang, J., Liu, C., Wu, D., Wang, X., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01201 · Cited by 12
Ye, Q., Gao, W., Feng, J., Li, X., Li, J., Yang, F., Li, L., Zi, M., Wu, X., Gao, H., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71185 · Cited by 11
Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
Bice, P. J., Nho, K. T., Ertekin‐Taner, N., & Saykin, A. J. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00934-4 · Cited by 18
Immune activation of the p75 neurotrophin receptor: implications in neuroinflammation
Danelon, V., Garrett-Thomson, S. C., Almo, S. C., Lee, F. S., & Hempstead, B. L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1305574 · Cited by 12
Vecchiarelli, H. A., Lopes, L. T., Paolicelli, R. C., Stevens, B., Wake, H., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_11 · Cited by 10
Shen, Y., Ali, M., Timsina, J., Wang, C., Do, A. N., Western, D., Liu, M., Gorijala, P., Budde, J., Liu, H., et al. (2024) · medRxiv · doi:10.1101/2024.01.12.24301242 · Cited by 11
Fournier, L. A., Phadke, R. A., Salgado, M., Brack, A., Nocon, J. C., Bolshakova, S., Grant, J. R., Padró-Luna, N. M., Sen, K., & Cruz‐Martín, A. (2024) · iScience · doi:10.1016/j.isci.2024.110800 · Cited by 9
Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis
Gezegen, H., Alaylıoğlu, M., Şahin, E., Swann, O., Veleva, E., Güven, G., Yaman, Ü., Salih, D. A. M., Bılgıç, B., Hanağası, H. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70162 · Cited by 16
The complement cascade in Alzheimer’s disease: modern implications of an ancient immune protagonist
Papavergi, M.-T., Bathini, P., Singh, B. B., & Lemere, C. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00916-y · Cited by 13
Magisetty, J., Gadiraju, B., & Kondreddy, V. K. R. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128867 · Cited by 11
Gene Expression at the Tripartite Synapse: Bridging the Gap Between Neurons and Astrocytes
Imrie, G., Gray, M. B., Raghuraman, V., & Farhy-Tselnicker, I. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-64839-7_5 · Cited by 8
Biofluid biomarkers for Alzheimer’s disease
Wang, S., Xie, S., Zheng, Q., Zhang, Z., Wang, T., & Zhang, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1380237 · Cited by 11
Nelson, N., Miller, V. K., & Broadie, K. S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1540052 · Cited by 11
Emerging evidence of context-dependent synapse elimination by phagocytes in the CNS
Shen, F.-S., Liu, C., Sun, H.-Z., Chen, X., Xue, Y., & Chen, L. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae098 · Cited by 9
Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer’s Disease
Li, D., Xie, Q., Xie, J.-K., Ni, M., Wang, J., Gao, Y., Wang, Y., & Tang, Q. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240022 · Cited by 8
Pituitary-immune bidirectional crosstalk under systemic inflammation
Li, Q. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002440 · Cited by 7
Mapping the Cerebrospinal Fluid Proteome in Bipolar Disorder
Göteson, A., Holmén‐Larsson, J., Celik, H., Pelanis, A., Sellgren, C. M., Sparding, T., Pålsson, E., Zetterberg, H., Blennow, K., Jönsson, L., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.01.007 · Cited by 10
Immunological Fluid Biomarkers in Frontotemporal Dementia: A Systematic Review
Erichsen, P. A., Henriksen, E. E., Nielsen, J. E., Ejlerskov, P., Simonsen, A. H., & Toft, A. D. (2025) · Biomolecules · doi:10.3390/biom15040473 · Cited by 9
Anderson, C. L., Gross, A. L., Pettigrew, C. A., Vazquez, J. P., Moghekar, A., Oh, S., Na, C. H., Albert, M., Worley, P. F., & Soldan, A. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.09.002 · Cited by 9
Self-citationPeng, J., Fan, T., Wang, J., Deng, Y., & Xu, R. (2026) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2026.2622722 · Cited by 8
Vazquez, J. P., Pettigrew, C. A., Zhu, Y., Anderson, C. L., Erus, G., Davatzikos, C. A., Miller, M. I., Moghekar, A., Oh, S., Na, C. H., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70216 · Cited by 8
Self-citationZhang, A., Zhang, X., Tang, X., Liu, M., Xie, J., Li, S., Cao, W., Zhou, H., & Xu, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05187-8 · Cited by 6
Yang, D., Xu, X., Zhuo, X., Cai, H., Wang, H., Liu, H., & Sun, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70646 · Cited by 5
Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures
Shrestha, H. K., Sun, H., Yarbro, J. M., Lee, D., Liu, D., Wang, E., McReynolds, M. G., Zhang, N., Xie, B., Yang, S., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.026 · Cited by 19
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
An, L., Binette, A. P., Hristovska, I., Vilkaite, G., Xiao, Y., Zendehdel, R., Dong, Z., Smets, B., Saloner, R., Tasaki, S., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04303-y · Cited by 12
Guo, Z., Hong, X., Wang, X., Chen, W., & Guo, Z. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02670-x · Cited by 7
Ferroptosis involvement in the neurotoxicity of flunitrazepam in zebrafish
Qin, Y., Lin, W., & Ren, Y. (2024) · Aquatic Toxicology · doi:10.1016/j.aquatox.2024.107128 · Cited by 5
Zhang, Z.-H., Chen, X., Sheng, Z.-H., Jiang, N., & Zou, W. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03545-w · Cited by 7
Lian, P., Cai, X., Wang, C., Zhai, H., Liu, P., Yang, X., Wu, Y., Ma, Z., Cao, X., & Xu, Y. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33836 · Cited by 5
Kirsebom, B., Nilsson, J., Vromen, E., Arnesen, P. M., Bjørnerud, A., Brinkmalm, A., Bråthen, G., Grøntvedt, G. R., Jarholm, J. A., Nordengen, K., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00899-w · Cited by 6
Zhang, Y., Watson, B. R., Rattan, A., Lee, T., Chawla, S., Geistlinger, L., Guan, Y., Lord, F. B., Ma, M., Miwa, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66048-5 · Cited by 10
The complement system in Alzheimer’s disease: mechanisms, biomarkers, and therapeutic implications
Liu, G., Deng, B., Han, X., Zhao, Y. C., Zeng, S., Yu, S., Wang, L., Wang, S., Wu, Y. J., Cai, L., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1798288 · Cited by 5
Xu, B., Bai, Y., Liu, Z., Li, J., Chen, K., Yan, Z., Wang, Y.-Y., Xu, J., Wang, H., Shi, F., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.001 · Cited by 4
Hou, Q., Liu, X., Feng, M., & Zhou, Z. (2023) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2023.105055 · Cited by 4
Zhang, Y., Watson, B. R., Rattan, A., Lee, T., Chawla, S., Geistlinger, L., Guan, Y., Ma, M., Caldarone, B. J., Song, W., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.22.568325 · Cited by 4
Wang, Y., Wu, T. Z., Gogineni, A., Tsai, M., Kielpinski, L. J., Mahajan, A., Pandey, S., Schachner, L. F., Tran, J. C., Wu, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.23.609240 · Cited by 5
Self-citationZhang, L., Levey, J., Abedin, M. J., Jo, H.-N., Odame, E., Howe, M., Douglas, K., Thoreen, E., McPherson, S. W., Roehrich, H., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.190227 · Cited by 4
Xu, Y., Peng, Y., Zhi, F., Yang, Y., Li, J., Fan, L., Xia, Y., & Shao, N. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106149 · Cited by 4
Tian, X., Xiong, M., Jiang, Z., Hong, R., & Wang, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-21874-x · Cited by 4
Zhang, L., Zhu, Y., & Zhang, S. (2025) · Communications Biology · doi:10.1038/s42003-025-09340-w · Cited by 5
Dai, L., Kirsebom, B., Wang, C., Zhang, M., Wang, Q., Ni, M., González‐Ortiz, F., Blennow, K., Shi, J., Fladby, T., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70472-6 · Cited by 6
Lv, J., Yao, L., Tang, L., Li, Q., Wang, L., Yan, X., Li, M., Peng, W., Zhang, H., Guo, J., et al. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.02.024 · Cited by 3
NPTX2 transfection improves synaptic E/I balance and performance in learning impaired aged rats
Severín, D., Koh, M. T., Moreno, C., Contreras, D., Contreras, A., Wesselborg, C., Bridi, M., Atufa, J., Branch, A., Worley, P. F., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102746 · Cited by 3
Self-citationOldham, D., Saviola, A. J., Álvarez, E., & Bruce, K. D. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.08.020 · Cited by 3
Huang, W.-C., Kast, R. J., Mandell, K. A. P., Dejanovic, B., Bonanno, K., Aryal, S., Farsi, Z., Wilde, J. J., Wang, D., Gao, X., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.15.623468 · Cited by 3
Self-citationComplement biosynthesis in human brain: Insights from single-nucleus transcriptomics of hippocampusPreprint
Nguyen, V. D., Bright, M., Zhou, Y., Morgan, B. P., & Zelek, W. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.06.652374 · Cited by 3
An, L., Binette, A. P., Hristovska, I., Vilkaite, G., Xiao, Y., Zendehdel, R., Dong, Z., Smets, B., Saloner, R., Tasaki, S., et al. (2025) · medRxiv · doi:10.1101/2025.06.27.25330344 · Cited by 3
Huang, X., Zeng, J., Hu, Z., Wu, Y., Zhang, G., Zhang, C., Yu, C., & Song, M. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05109-8 · Cited by 2
Genetic Mechanisms of Experience-Dependent Neuronal Plasticity
West, A. E. (2025) · Annual Review of Genetics · doi:10.1146/annurev-genet-020325-103824 · Cited by 5
Gallo, M. T., Golinelli, A., Rizzi, C., Fumagalli, F., Homberg, J. R., Brivio, P., & Calabrese, F. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117632 · Cited by 2
Meng, D., Chen, Y., Cui, C., Huang, M., Zhu, J., Lu, H., Zhang, H., & Sun, D. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504723 · Cited by 3
Synapse-associated neuropathological markers in Alzheimer's disease
Barrantes, F. J. (2026) · Brain · doi:10.1093/brain/awag117 · Cited by 2
Rothschadl, M. J., Sathyanesan, M., & Newton, S. S. (2023) · Life · doi:10.3390/life13091826 · Cited by 2
Low synaptic and neurosecretory proteins in cerebrospinal fluid in early parkinsonian disease
Jakobsson, P., Nilsson, J., Nygren, M., Zetterberg, H., Blennow, K., Constantinescu, R., Constantinescu, J., Brinkmalm, A., & Bäckström, D. C. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123683 · Cited by 3
NPTX2-Centered Cognitive Resilience Mechanisms in the Context of AD PathologyPreprint
Lao, Y., Xiao, M.-F., Ji, S., Piras, I. S., Kim, K., Bonfitto, A., Song, S., Aldabergenova, A., Na, C. H., Sloan, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.17.683150 · Cited by 3
Self-citation
Metadata
- Authors
- Zhou, J., Wade, S. D., Graykowski, D., Xiao, M.-F., Zhao, B., Giannini, L. A. A., Hanson, J. E., van Swieten, J. C., Sheng, M., Worley, P. F., & Dejanovic, B.
- Affiliations
- Johns Hopkins University (US)
- Broad Institute (US)
- Erasmus MC (NL)
- Genentech (US)
- Alzheimer Center, Department of Neurology, Erasmus University Medical Center, Rotterdam, 3015 GD, Netherlands.
- Corresponding author
- Sheng, Morgan
- Worley, Paul F.
- Dejanovic, Borislav
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2023-03-29
- Volume
- 15
- Issue
- 689
- Pages
- eadf0141-eadf0141
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC10467038
- OpenAlex
- W4361290848
- Cited by
- 152
- References
- 58
- Citations by year
- 2026: 43 · 2025: 53 · 2024: 38 · 2023: 18
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Translational Medicine (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (AG065169)
- Stanley Center for Psychiatric Research, Broad Institute
- National Institute on Aging (P01AG009973, R01AG072643, U19AG065169)
- National Institute of Neurological Disorders and Stroke (R35NS097966)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NPTX2, C1q, complement overactivation, microglia, synaptic pruning, neurodegeneration, frontotemporal dementia, Alzheimer's disease, neuroinflammation, tauopathy, cerebrospinal fluid biomarkers, C3 activation, AAV gene therapy
- MeSH terms
- Pentraxins, Aged, Animals, Complement System Proteins, Humans, Synapses, Complement C1q, Microglia, Mice, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.